Using AI and Endocuff Vision to Improve Colonoscopy Results
Comparison of The Adenoma Detection Rate Between Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision and Standard Colonscopy: A Randomized Controlled Study
This study is testing if using artificial intelligence with a special tool called Endocuff can help doctors find more polyps during colonoscopy in adults over 20.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | E-DA Hospital Academic / other |
| Locations | 1 site (Kaohsiung City) |
| Trial ID | NCT05863208 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of combining artificial intelligence (AI) with Endocuff vision in improving the adenoma detection rate (ADR) during colonoscopy. It is a prospective, single-blinded, randomized controlled trial that compares three groups: one using AI with Endocuff vision, another using AI alone, and a third using standard colonoscopy techniques. Eligible participants are adults over 20 years old undergoing outpatient sedative colonoscopy, and the study will assess various parameters including polyp detection and bowel preparation quality. The goal is to determine if the combination of these technologies can enhance the quality of colonoscopy and reduce the risk of interval colorectal cancer.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 20 years old who are scheduled for outpatient sedative colonoscopy.
Not a fit: Patients with a history of inflammatory bowel disease, colorectal cancer, or other specified conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the detection of adenomas during colonoscopy, potentially reducing the incidence of colorectal cancer.
How similar studies have performed: While the use of AI in colonoscopy is gaining traction, the specific combination of AI and Endocuff vision is a novel approach that has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients over 20 years old are undergoing outpatient sedative colonoscopy in the E-Da Hospital, E-Da cancer Hospital and Chung Shan Medical University Hospital in Taiwan Exclusion Criteria: * A prior history of of inflammatory bowel disease, colorectal cancer, previous bowel resection, Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes * Bleeding tendency * For scheduled endoscopic treatment
Where this trial is running
Kaohsiung City
- E-DA Hospital — Kaohsiung City, Taiwan (Recruiting)
Study contacts
- Study coordinator: Ying Nan Tsai, MD
- Email: littlepig9933@gmail.com
- Phone: +88676150022
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.